These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2299990

  • 1. Low-density lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL, Caslake MJ, Boulton-Jones JM, Dagen M, Packard CJ, Shepherd J.
    Metabolism; 1990 Feb; 39(2):187-92. PubMed ID: 2299990
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria.
    Warwick GL, Packard CJ, Demant T, Bedford DK, Boulton-Jones JM, Shepherd J.
    Kidney Int; 1991 Jul; 40(1):129-38. PubMed ID: 1921148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
    Krämer-Guth A, Nauck M, Pavenstädt H, Königer M, Wieland H, Schollmeyer P, Wanner C.
    J Am Soc Nephrol; 1994 Oct; 5(4):1081-90. PubMed ID: 7849247
    [Abstract] [Full Text] [Related]

  • 10. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
    Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.
    Kidney Int; 2000 Sep; 58(3):1238-46. PubMed ID: 10972686
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipoprotein metabolism in nephrotic syndrome in childhood.
    Oetliker OH, Mordasini R, Lütschg J, Riesen W.
    Pediatr Res; 1980 Jan; 14(1):64-6. PubMed ID: 7360522
    [Abstract] [Full Text] [Related]

  • 15. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
    Wang L, Shearer GC, Budamagunta MS, Voss JC, Molfino A, Kaysen GA.
    Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171
    [Abstract] [Full Text] [Related]

  • 16. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment.
    Wheeler DC, Bernard DB.
    Am J Kidney Dis; 1994 Mar; 23(3):331-46. PubMed ID: 8128933
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO, Alaupovic P.
    Am J Nephrol; 1990 Mar; 10 Suppl 1():69-75. PubMed ID: 2256478
    [Abstract] [Full Text] [Related]

  • 18. Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome.
    Jüngst D, Caselmann WH, Kutschera P, Weisweiler P.
    Clin Chim Acta; 1987 Sep 30; 168(2):159-67. PubMed ID: 3677414
    [Abstract] [Full Text] [Related]

  • 19. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M, Salamatullah Q, Ferdous Z, Hussain MA.
    Bangladesh Med Res Counc Bull; 1976 Jun 30; 2(1):64-70. PubMed ID: 190998
    [Abstract] [Full Text] [Related]

  • 20. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN, Le NA, Gibson JC.
    J Clin Invest; 1985 Feb 30; 75(2):614-23. PubMed ID: 3973021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.